A little-known life sciences and biopharma hedge fund specialist is launching its fourth private equity fund.
Cormorant Asset Management disclosed in a regulatory filing it has raised nearly $253 million from 34 investors for Cormorant Private Healthcare Fund IV.
It is targeting a total of $400 million, according to the filing.
The
